67 related articles for article (PubMed ID: 1462838)
1. Procoagulant changes induced by oral contraceptives are balanced by an increased fibrinolytic tendency.
Mackie IJ; Campbell S; Gallimore M; Robinson G; Machin SJ
Agents Actions Suppl; 1992; 38 ( Pt 2)():310-9. PubMed ID: 1462838
[TBL] [Abstract][Full Text] [Related]
2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
3. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
4. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
5. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
7. A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
Briggs MH
J Reprod Med; 1983 Jan; 28(1 Suppl):92-9. PubMed ID: 6403706
[TBL] [Abstract][Full Text] [Related]
8. [Haemostatic and fibrinolytic variables in women with anorexia nervosa].
Sobieszczańska S; Rabe-Jabłońska J
Psychiatr Pol; 2005; 39(4):741-59. PubMed ID: 16237979
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
10. [The behavior of coagulation and fibrinolysis factors with different streptokinase doses].
Poliwoda H; Krohn HP; Steuber H
Med Lab (Stuttg); 1968 Nov; 21(11):252-61. PubMed ID: 5714595
[No Abstract] [Full Text] [Related]
11. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors.
Rankinen T; Rauramaa R; Väisänen S; Penttilä IM; Uusitupa M
Thromb Haemost; 1994 Feb; 71(2):180-3. PubMed ID: 8191395
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
13. Changes in haemostatic factors and activation products after exercise in healthy subjects with different ages.
van den Burg PJ; Hospers JE; van Vliet M; Mosterd WL; Bouma BN; Huisveld IA
Thromb Haemost; 1995 Dec; 74(6):1457-64. PubMed ID: 8772220
[TBL] [Abstract][Full Text] [Related]
14. Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis.
de Visser MC; Poort SR; Vos HL; Rosendaal FR; Bertina RM
Thromb Haemost; 2001 Jun; 85(6):1011-7. PubMed ID: 11434677
[TBL] [Abstract][Full Text] [Related]
15. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
Petersen KR; Skouby SO; Jespersen J
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
[TBL] [Abstract][Full Text] [Related]
16. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
17. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
18. Coagulation changes following hepatic revascularization during liver transplantation.
Harper PL; Luddington RJ; Jennings I; Reardon D; Seaman MJ; Carrell RW; Klink JR; Smith M; Rolles K; Calne R
Transplantation; 1989 Oct; 48(4):603-7. PubMed ID: 2529679
[TBL] [Abstract][Full Text] [Related]
19. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
Ferreira AC; Montes MB; Franceschini SA; Toloi MR
Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
[TBL] [Abstract][Full Text] [Related]
20. [Hemostatic balance during treatment with the newest contraceptives].
Petersen KR; Skouby SO; Sidelmann J; Jespersen J
Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]